Shingles vaccine cuts dementia risk

Recent research has uncovered a significant association between the shingles vaccine and reduced dementia risk.

Multiple studies now provide substantial evidence that this vaccination, primarily designed to prevent painful skin rashes in older adults, may offer unexpected neurological benefits.

With dementia affecting more than 55 million people globally and ranking as the leading cause of death in some countries, this discovery represents a potentially game-changing approach to reducing your risk of cognitive decline.